Pre-clinical validation and demonstration of PeptiCHIP: an immunopurification microfluidic device and software for (neo)antigen identification and prioritization

Project Information

PeptiCHIP

Grant agreement ID: 101112948

DOI

10.3030/101112948

Project closed

EC signature date 13 March 2023

Start date 1 April 2023

End date 30 September 2025

Funded under

• The European Innovation Council (EIC)

Total cost

€ 2 226 280,00

EU contribution

€ 2 226 280,00

Coordinated by

VALO THERAPEUTICS OY
Finland

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomes

Author(s): Fernando Perez-Villatoro, Aleksandra Shabanova, Lilian van Wagensveld, Ada Junquera, Iga Niemiec, María M. Hincapié-Otero, Ziqi Kang, Matias M. Falco, Kürşat Birgin, Sarah Wolf, Ella Anttila, Gayani Anandagoda, Julia Casado, Eric Marcus, Duco Gaillard, Essi Kahelin, Foteini Chamchougia, Matilda Salko, Saundarya Shah, Salvatore Russo, Jacopo Chiaro, Mikaela Grönholm, Joseph Ndika, Otto K. Kari, iCAN iCAN, Gabe S. Sonke, Koen K. Van de Vijver, Rutgerus FPM Kruitwagen, Maaike van der Aa, Anni Virtanen, Vincenzo Cerullo, Anna Vähärautio, Peter K. Sorger, Hugo M. Horlings, Anniina Farkkila
Published in: Cancer Discovery, 2026, ISSN 2159-8274
Publisher: American Association for Cancer Research (AACR)
DOI: 10.1158/2159-8290.CD-25-1492